Your browser doesn't support javascript.
loading
Low muscle mass measured at T12 is a prognostic biomarker in unresectable oesophageal cancers receiving chemoradiotherapy.
McSweeney, Dónal Michael; Raby, Sophie; Radhakrishna, Ganesh; Weaver, Jamie; Green, Andrew; Bromiley, Paul Alan; van Herk, Marcel; McWilliam, Alan.
Afiliação
  • McSweeney DM; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK; Radiotherapy Related Research, The Christie Foundation Trust, Manchester M20 4BX, UK. Electronic address: donal.mcsweeney@manchester.ac.uk.
  • Raby S; Department of Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester M20 4BX, UK.
  • Radhakrishna G; Department of Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester M20 4BX, UK.
  • Weaver J; Department of Medical Oncology, The Christie Hospital NHS Foundation Trust, Manchester M20 4BX, UK.
  • Green A; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK; Radiotherapy Related Research, The Christie Foundation Trust, Manchester M20 4BX, UK.
  • Bromiley PA; Division of Informatics, Imaging and Data Sciences, University of Manchester, M13 9PL, UK.
  • van Herk M; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK; Radiotherapy Related Research, The Christie Foundation Trust, Manchester M20 4BX, UK.
  • McWilliam A; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK; Radiotherapy Related Research, The Christie Foundation Trust, Manchester M20 4BX, UK.
Radiother Oncol ; 186: 109764, 2023 09.
Article em En | MEDLINE | ID: mdl-37385375

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Sarcopenia / Linfopenia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Sarcopenia / Linfopenia Idioma: En Ano de publicação: 2023 Tipo de documento: Article